Molbio Diagnostics IPO Allotment Status Live: Check Your Allotment

The Molbio Diagnostics IPO allotment status will be available on Thursday, August 13, 2026. Investors can check their allotment status through the IPOwiz App, Kfin Technologies Website, BSE, or their demat/bank account. Below is a step-by-step guide to help you check your status:
Latest Grey Market Premium (GMP)
The grey market premium shows how investors feel about the IPO before listing. Here's how Molbio Diagnostics GMP has changed:
| Date | IPO Price | GMP | Expected Listing Price |
|---|---|---|---|
| August 13 (Today) | ₹807.00 | ₹154.00 | ₹961 (19.10%) |
Join us on Telegram: Click Here
Final Subscription in Molbio Diagnostics:
| Category | Subscription |
|---|---|
| Qualified Institutional Buyers | 186.39x |
| Small HNI (Below ₹10L) | 47.76x |
| Big HNI (Above ₹10L) | 50.82x |
| Retail Investors | 12.97x |
| Total | 70.26x |
Allotment Chances in Molbio Diagnostics:
| Category | Allotment Chances |
|---|---|
| Small HNI | 1 out of 46 |
| Big HNI | 1 out of 10 |
| Retail Investors | 1 out of 11 |
How to Check Molbio Diagnostics IPO Allotment Status
Molbio Diagnostics IPO allotment status will be available on Thursday, August 13, 2026. Here's how you can check:
Option 1: Via IPOwiz App
- Download the IPOwiz App from the Play Store.
- Add the PAN numbers you want to check in the PAN section.
- Go to the Allotted Section and select Molbio Diagnostics IPO.
- View the allotment status for the saved PAN numbers.
Option 2: Via Kfin Technologies Website
- Visit the Kfin Technologies IPO Allotment Page.
- Select Molbio Diagnostics Limited from the drop-down menu.
- Enter your PAN number, application number, or demat account details.
- Click Search to view your allotment status.
Option 3: Via BSE Website
- Go to the BSE Website.
- Choose Molbio Diagnostics IPO from the list.
- Enter your PAN number, application number, or demat account details.
- Click Search to check your status.
Option 4: Via Demat Account
- Log in to your demat or trading account.
- Check if the allotted shares are credited. If yes, the shares will reflect in your account.
Option 5: Via Bank Account
- Log in to the bank account used for the IPO application.
- Check if the amount is debited. If debited, it means you’ve been allotted shares. If not, the amount will be refunded.
Molbio Diagnostics IPO Key Dates
- IPO Open Date: August 10, 2026
- IPO Close Date: August 12, 2026
- Allotment Date: August 13, 2026
- Refund Date: August 14, 2026
- Demat Credit Date: August 14, 2026
- Listing Date: August 17, 2026
About Molbio Diagnostics
Molbio Diagnostics Limited (incorporated in 2000 as Molbio Diagnostics Private Limited) is a point-of-care (POC) diagnostics company focused on delivering accurate, rapid, and cost-effective healthcare technologies for infectious and non-communicable diseases. The company developed the 'Truenat' platform, a portable polymerase chain reaction (PCR) system that enables decentralized molecular testing for 30 diseases across 42 assays, patented in over 100 countries. Its Truenat TB test is WHO-endorsed for initial TB diagnosis and rifampicin resistance detection.
FAQs
1. When will the Molbio Diagnostics IPO allotment be out?
Molbio Diagnostics IPO allotment will be available on August 13, 2026.
2. How to check Molbio Diagnostics IPO allotment status?
You can check the allotment via IPOwiz App, Kfin Technologies website, BSE, or your demat account.
3. What is the expected listing price of Molbio Diagnostics IPO?
Based on ₹154.00 GMP, the expected listing price is ₹961 (19.10% above IPO price).
4. What are the allotment chances for retail investors?
Retail investors have roughly a 1 out of 11 chance.
5. When will shares be credited to demat accounts?
Shares will be credited by August 14, 2026 for successful allotments.
6. When is Molbio Diagnostics IPO listing date?
The shares will list on BSE and NSE on August 17, 2026.
7. Can I sell shares on listing day?
Yes, you can sell allotted shares when trading begins on August 17.
8. Is Molbio Diagnostics IPO good for long-term?
The GMP indicates a strong listing gain. Given its robust diagnostics pipeline and WHO endorsements, it may be evaluated for long-term investments post-listing.
For further queries contact the IPO registrar, Kfin Technologies.